Research output per year
Research output per year
Project Details
Description
Two studies called Biologics for Children with Rheumatic Diseases (BCRD) and BSPAR Etanercept Study (BSPAR ETN) are underway at hospitals throughout the UK to look at the safety and effectiveness of biologic and biosimilar treatment for Juvenile Idiopathic Arthritis (JIA).
As part of the studies, long term follow-up information regarding changes to the disease and any newer illnesses is collected to determine the safety and effectiveness of these types of treatments.
As part of the studies, long term follow-up information regarding changes to the disease and any newer illnesses is collected to determine the safety and effectiveness of these types of treatments.
| Acronym | BCRD/BSPAR |
|---|---|
| Status | Not started |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
-
Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis (JIA).
UK JIA Biologic Registers, 7 Aug 2022, (Accepted/In press) In: Rheumatology.Research output: Contribution to journal › Article › peer-review
Open Access -
Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries
Kearsley-Fleet, L., Klotsche, J., van Straalen, J. W., Costello, W., D’Angelo, G., Giancane, G., Horneff, G., Klein, A., Láday, M., Lunt, M., de Roock, S., Ruperto, N., Schoemaker, C., Vijatov-Djuric, G., Vojinovic, J., Vougiouka, O., Wulffraat, N. M., Hyrich, K., Minden, K. & Swart, J. F., 6 Oct 2021, In: Rheumatology (Print). keab641.Research output: Contribution to journal › Article › peer-review
Open Access -
Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study
Kearsley-Fleet, L., Heaf, E., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T., Thomson, W., Hyrich, K., Biologics for Children with Rheumatic Diseases Study (BCRD) & British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN), 1 Apr 2020, In: The Lancet Rheumatology. 2, 4, p. E217-E226Research output: Contribution to journal › Article › peer-review
Open Access